More patients now pay $0 out of pocket for DESCOVY FOR PrEP® than for generic FTC/TDF, regardless of insurance.1*†
*With or without secondary benefits.
†Source: Data on file; as of 04/01/2026.
Over 98% of Gilead Advancing Access® Co-pay Savings Program users pay $0 each month for DESCOVY FOR PrEP1‡§
- The Gilead Co-pay Savings Program may help eligible, commercially insured individuals lower their out-of-pocket costs‡
- This program covers up to $7200 in co-pays per year with no monthly limit for DESCOVY FOR PrEP
Individuals prescribed DESCOVY® can get started online (available 24/7) or by phone:
‡Co-pay Savings Program support is available for eligible, commercially insured patients only. Additional restrictions may apply. Subject to change; for full terms and conditions, visit GileadAdvancingAccess.com/copay-coupon-card. This is not health insurance.
§Source: Data on file; as of 10/31/25.
Learn more about Advancing Access
Benefits
investigation
Medication
Assistance Program
Prior Authorization
information
Other Advancing Access resources
Do you have questions about the Advancing Access program?
Visit Advancing Access FAQsLive support is available for eligible individuals
Advancing Access specialists can help provide insurance information support, including determining prior authorization and appeals process requirements, and connect people to available resources to help them navigate coverage.
They can also help individuals prescribed DESCOVY understand and navigate health insurance and Gilead medication costs. For more information, you can direct individuals to visit GileadAdvancingAccess.com/patient or call 1-800-226-2056.
You may also be interested in:
FTC/TDF=emtricitabine/tenofovir disoproxil fumarate; PrEP=pre-exposure prophylaxis.